Summary and conclusion
In summary, we have found biomonitoring to be a valuable adjunct to medical surveillance in a number of situations. Although the potential benefits are relatively easy to demonstrate, clear guidance must be provided to assure that no harm will result from a biomonitoring program. A critical step in this regard is attention to the communication of objectives and results. This is especially true where biomonitoring of carcinogenic substances or surrogate measures for these substances are being considered. In such situations, action levels are helpful for interpretative purposes and immediate decision-making, but not for determining individual health risks. However, the quantitative results may be suitable for use in future health studies and risk assessments.
Similar content being viewed by others
References
Aitio A (1994) Biological monitoring today and tomorrow. Scandinavian journal of work, environment & health, 20 special issue: 46–58
Will W (1992) Biomonitoring in der arbeitsmedizinischen Praxis. In: Florian H-J et al. (eds) Arbeitsmedizin aktuell. Stuttgart, Gustav Fischer Verlag, chap. 9.4, pp. 1–9
Henschler D, Lehnert G (eds) (1994) Biological exposure values for occupational toxicants and carcinogens, Vol. 1. Weinheim, VCH Verlagsgesellschaft
Zober A, Ott MG (1992) Risk assessment and risk management in the chemical industry. In: World Health Organization (ed.) Occupational health in the chemical industry: selected papers from the 23rd ICOH congress on occupational health 22–28 September 1990, Montreal, Canada and the XIX Medichem congress 17–20 September 1991, Basle, Switzerland. Copenhagen, World Health Organization, Regional Office for Europe, pp 145–160
Schulte PA, Perera FP (eds) (1993) Molecular epidemiology: principles and practices. San Diego, Academic Press
Pearce N et al. (1995) Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology 6:190–194
Kusters E (1992) Biological monitoring of MDA. Br J Ind Med 49:72
Zober A et al. (1992) Morbidity study of N-vinylpyrrolidone production workers. In: World Health Organization (ed.) Occupational health in the chemical industry: selected papers from the 23rd ICOH congress on occupational health 22–28 September 1990, Montreal, Canada and the XIX Medichem congress, 17–20 September 1991,Basle, Switzerland. Copenhagen, World Health Organization, Regional Office for Europe, pp 31–43
Will W (1992) Action-level regarding PAHs, unpublished report, Ludwigshafen. personal communication
Zober A et al. (1995) Study of morbidity of personnel with potential exposure to vinclozolin. Occupational Environ Med 52:233–241
Gamer RC et al. (eds) (1991) Human carcinogen exposure: biomonitoring and risk assessment. Oxford, Oxford University Press
CEFIC (ed) (1995) Discussion paper on some practical aspects of the biological monitoring of exposure to genotoxic substances. Brussels, CEFIC
Jongeneelen FJ, Anzion RBM (1991) Hydroxypyrene. In: Angerer J, Schaller KH (eds) Analyses of hazardous substances in biological materials, Vol. 3. Weinheim, VCH Verlagsgesellschaft, pp 157–168
Jongeneelen FJ et al. (1988) Metabolites of polycyclic aromatic hydrocarbons in urine of exposerd workers. Toxicol Environ Chem 16:295–307
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zober, A., Will, W. Biological monitoring and risk assessment in occupational settings. Int Arch Occup Environ Health 68, 389–393 (1996). https://doi.org/10.1007/BF00377857
Issue Date:
DOI: https://doi.org/10.1007/BF00377857